Abstract Incorporation rates of the enantiomers of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolite 3,4-methylenedioxyamphetamine (MDA) into hair and nails were investigated after controlled administration. Fifteen subjects without MDMA use received two doses of 125 mg of MDMA. Hair, nail scrapings, and nail clippings were collected 9-77 days after the last administration (median 20 days). Hair samples were analyzed in segments of 1-to 2-cm length. After chiral derivatization with N-(2,4-dinitro-5-fluorophenyl)-L-valinamide, MDMA and MDA diastereomers were analyzed by liquid chromatography-tandem mass spectrometry. Highest concentrations in hair segments corresponded to the time of MDMA intake. They ranged from 101 to 3200 pg/mg and 71 to 860 pg/mg for R-and S-MDMA, and from 3.2 to 116 pg/mg and 4.4 to 108 pg/mg for R-and S-MDA, respectively. MDMA and MDA concentrations in nail scrapings and clippings were significantly lower than in hair samples. There was no significant difference between enantiomeric ratios of R/S-MDMA and R/S-MDA in hair and nail samples (medians 2.2-2.4 for MDMA and 0.85-0.95 for MDA). Metabolite ratios of MDA to MDMAwere in the same range in hair and nail samples (medians 0.044-0.055). Our study demonstrates that administration of two representative doses of MDMA was detected in the hair segments corresponding to the time of intake based on average hair growth rates. MDMA was detected in all nail samples regardless of time passed after intake. Comparable R/S ratios in hair and nail samples may indicate that incorporation mechanisms into both matrices are comparable.
Introduction
The analysis of keratinized matrices such as hair is of considerable importance in forensic toxicology. Main applications are long-term monitoring of drug and alcohol consumption, e.g., of drug users or dealers, in abstinence controls for regranting driver's license, in postmortem investigations or in drug-facilitated crimes [1, 2] . In some cases, it is necessary to evaluate whether an individual has taken the drug on a regular basis or whether a single or sporadic intake is more likely. In order to gain time-resolved information on an individual's drug exposure, the Society of Hair Testing (SoHT) recommends analysis of hair segments of 1 to 3 cm [3] . Based on an average growth rate of 1 cm per month (range 0.7-1.4 cm per month), the time frame of drug intake can be estimated [1] . Several reports describe the detection of drug not only in hair segments corresponding to the expected time of intake/administration but also in adjacent segments [4] [5] [6] [7] . This may render interpretation of analysis results difficult. For amphetamines, a positive correlation after controlled administration of a low (4×10 mg) and high (4×20 mg) dose of sustained release S-(+)-methamphetamine hydrochloride was demonstrated within subjects but not between subjects [8] .
Nails, another keratinzed matrix, are being discussed as an alternative to hair because nails also accumulate drugs [9] [10] [11] [12] [13] [14] [15] . Average growth rates were reported to range from 1.9 to 4.4 (mean 3.47) mm/month for fingernails and 0.9 to 2.1 (mean 1.62) mm/month for toenails [10, 11, 16, 17] . Investigations on paired hair and nail analysis for amphetamines delineated similar [18] or higher concentrations in hair [19] , but one group reported slightly higher amphetamine concentrations in fingernails compared to hair [20] .
The exact incorporation mechanism for drug incorporation into hair and nails is not sufficiently understood [1, 10] . For hair, proposed mechanisms are passive diffusion and transport phenomena from the systemic blood circulation across the cell membrane of growing matrix cells at the hair follicle. This incorporation is recognized to be favored by melanin and dependent on, i.e., physico-chemical drug properties [1, 21, 22] . Furthermore, it was demonstrated that drug incorporation takes place via sweat/sebum and external contamination [1, 23] .
Studies on the incorporation pathways into nails were performed after a single dose of zolpidem [24, 25] . The germinal nail matrix and nail bed were identified as drug incorporation regions. Furthermore, sweat presumably contributes to a large extent to drug incorporation into the nail as drug could already be detected in fingernail clippings 24 h after drug intake [25] .
The investigation of drug stereoisomers could hypothetically provide insights into incorporation mechanisms into hair and nail. It is recognized that enantiomers can display significantly distinct pharmacokinetic and pharmacodynamic behavior implying differences in affinity to metabolizing enzymes or receptor sites [26] .
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is an illicit drug mostly traded as racemic mixture [27] . It belongs to the most prevalent drugs involved in forensic and driving under the influence cases [28] [29] [30] [31] [32] . MDMA is used for its entactogenic effects and stimulation of the central nervous system [33] which are mainly attributed to the S-MDMA enantiomer [34] . The R-enantiomer was reported to be more abundant in blood, plasma, urine, vitreous humor, bile, and liver representing its enantioselective metabolism most likely because of the elimination of the S-enantiomer from plasma at a higher rate [35] [36] [37] [38] . MDMA exhibits non-linear pharmacokinetics in a dose range compatible with recreational use [39] . It is primarily metabolized to 3,4-dihydroxymethamphetamine (DHMA) by the cytochrome P450 isoenzyme CYP2D6 [34] , which is polymorphic [40] . DHMA is further metabolized to 4-hydroxy-3-methoxymethamphetamine (HMMA) by O-demethylation [29] . 3,4-Methylenedioxyamphetamine (MDA) is a minor metabolite of MDMA formed by N-demethylation [34] ; the average concentration of MDA 24 h after ingestion of 125 mg MDMA hydrochloride was reported to be about sevenfold lower compared to MDMA [41] .
The present study aims at analyzing hair and nail samples for enantiomers of MDMA and its metabolite MDA after controlled administration of two doses (125 mg each) of racemic MDMA. The study focused on the metabolite MDA rather than investigating DHMA and HMMA which are more abundant in blood and urine as MDA is the only routinely tested metabolite considered for the interpretation of hair analysis results. Furthermore, our preliminary studies on hair samples positive for MDMA had been negative for DHMA and HMMA had either been negative or only traces had been detected (data not published).
Segmental analysis of hair samples is performed to study whether drug detection in a hair segment can be correlated to the respective time period of MDMA intake. Nail samples are evaluated as an alternative specimen to hair when testing for single/sporadic MDMA intake. The enantioselective patterns of MDMA and MDA in hair and nails are examined to gain insights whether incorporation mechanisms into these matrices differ. To our knowledge, the present study is the first report on the incorporation of MDMA and MDA enantiomers in hair and nail samples of non-drug using participants following controlled intake of MDMA.
Experimental Study design and sample collection
Hair and nail samples were obtained from a double-blind, placebo-controlled, cross-over study performed at the University Hospital of Basel, Switzerland, to investigate pharmacokinetic effects of MDMA [42] . The study was conducted in accordance with the Declaration of Helsinki and International Conference on Harmonization Guidelines in Good Clinical Practice and approved by the Ethics Committee of the Canton of Basel, Switzerland, and the Swiss Agency for Therapeutic Products (Swissmedic). All participants provided written informed consent. Only subjects with no prior regular MDMA use were included. Five subjects had previously used MDMA (<5 times) at least 2 months prior to the study start. Abstinence from drugs of abuse during the study was checked by repeated urine tests [42] . Subjects (n= 15) were administered two doses of pharmaceutical grade racemic MDMA (MDMA hydrochloride 125 mg) in capsules. These administrations represent recreational doses for drugnaive subjects and correspond to a mean (±standard deviation) dose of 1.89±0.30 mg/kg body weight [40] . The time interval between the two administrations was different for each subject ranging between 9 and 105 days (median 18 days). Head hair samples, nail scrapings, and clippings were collected; 13 nail samples were from the ring finger and 3 from the big toe. Nails were wiped twice with acetone prior to sample collection. The time between last MDMA intake and sample collection ranged from 9 to 77 days (median 20 days). All subjects were phenotyped and genotyped for CYP2D6 activity [42] . Fourteen participants were extensive metabolizers, and 1 participant (no. 1) was a poor metabolizer (Table 1) .
Materials
Deuterated and undeuterated racemic standards were obtained as calibrated methanolic solutions from Lipomed (Arlesheim, Switzerland). N-(2,4-dinitro-5-fluorophenyl)-L-valinamide (DNPV) for derivatization and all other chemicals were purchased from Sigma-Aldrich Chemie GmbH (Buchs, Switzerland). Solvents for washes, extraction, and analysis by liquid chromatography-tandem mass spectrometry (LC-MS/MS), all of HPLC grade, were obtained from SigmaAldrich Chemie GmbH (Buchs, Switzerland). Drug-free hair and nail samples for method validation were provided by drug-naive volunteers.
Analytical methods

Hair and nail sample preparation
Routine hair testing in our lab considers the proximal 5 cm for analysis. Hair samples in this study were segmented in three 1-cm segments from proximal to distal to narrow down the time windows corresponding to the time of the two MDMA administrations during the study period of 3 months. The consecutive 2-cm segments were analyzed to monitor the time before the study (Table 1) . Hair segments were washed separately with 2 mL water and 2 mL acetone for 2 min, and nail clippings were washed once with 1 mL water for 30 s by vortexing. On average, 20 mg hair segments, 5 mg clippings, and 1-5 mg scrapings were used for analysis. Hair and nail clippings were pulverized at 25 Hz for 8 min using a mixer mill (MM 200 Retsch, Switzerland). For extraction, 0.1-mL IS solution (50 ng/mL) containing MDMA-d5 and MDA-d5 and 0.9-mL MeOH were added, and samples were sonicated for 4 h at 50 to 60°C. Extracts were filtered through a 0.22 um PTFE syringe filter (BGB, Boeckten, Switzerland) and 50 μL formic acid (20 %, v/v) were added for evaporation at 50°C under nitrogen. The residue was reconstituted in 80-μL carbonate buffer (1 M, pH 9). For derivatization of MDMA and MDA, 30 μL 0.3 % DNPV in acetone were added, and vials were placed in a heating block at 50°C for 30 min as previously described [43, 44] 
LC-MS/MS parameters
Analytes were separated on a Phenomenex Kinetex C18 column (100×2.1 mm, 2.6 μm) using a Thermo Fisher Ultimate 3000 high-performance liquid chromatography (UHPLC) system and detected by an Applied Biosystems 5500 Q Trap linear ion trap triple quadrupole mass spectrometer (Sciex, Darmstadt/ Germany) with Analyst software (Version 1.6). The following mobile phase gradient of eluent A and B was adjusted: 0-1 min: 2 % B; 1-2 min: increase to 40 % B; 2-9.3 min: increase to 60 % B; 9.3-9.5 min: increase to 98 % B; 9.5-10.5 min: holding at 98 % B; 10.5-10.8 min: decrease to 2 % B; 10.8-12 min: holding at 2 % B. The flow rate was 0.4 mL/min. The column temperature was maintained at 35°C and the injection volume was 10 μL. The MS instrument was operated in positive electrospray ionization and multiple reaction monitoring (MRM) mode. Retention times, MRM transitions, and MS settings are given in Table 2 . The criteria for positive identification were matching retention time and presence of two MRM transitions (one quantifier, one qualifier). Quantification was achieved using the most abundant transition of each precursor to the respective product ion. Further MS operation parameters were as previously reported by Steuer et al. [43] .
Method validation
Standard solutions of racemic MDMA and MDA for six calibrators and quality controls (QC) at two concentration levels, low and high, were prepared separately by diluting the respective stock solution with acetonitrile. Concentrations are given in Table 3 . An internal standard solution of racemic MDMAd5 and MDA-d5 in acetonitrile was prepared at a concentration of 50 ng/mL. Blank matrix of 20 mg hair and 5 mg nail were spiked with 100 μL of each calibrator or QC solution. Calibration curves and quality control samples (in duplicate) were analyzed on 5 days. Quantitation was performed by determining the analyte to IS peak area ratios. A weighted linear regression model (1/concentration) was applied. The lower limit of quantification (LLOQ) and limit of detection (LOD) was chosen to be the concentration resulting in a peak height with a signal-to-noise ratio of 10 and 3, respectively. For determination of accuracy, repeatability, and precision, QC samples were analyzed in duplicate over 5 days using daily calibration curves. Matrix effects were studied according to Matuszewski et al. [45] by dividing the peak area of analytes in hair samples of different sources (n=5) spiked at the concentration levels LOW and HIGH after extraction by the mean peak area of analytes in neat QCs at the same concentration. Values were multiplied by 100 considering 75-125 % as acceptable threshold. The method was validated according to international guidelines [46] . 
Results
Method validation
The method was validated based on the Guidelines for Quality Control in Forensic-Toxicological Analyses of the GTFCh for the criteria selectivity, LOD, LLOQ, linearity of calibration, accuracy, repeatability, precision, and matrix effects [46] . Validation data are given in Table 3 . Calibration curves were linear over the concentration range of 0.5 to 500 pg/mg for hair samples and 2.0 to 2000 pg/mg for nail samples. The criteria for accuracy, repeatability, and precision were fulfilled as bias and standard deviations were within ±15 % for the tested concentration levels LOW and HIGH. In case of S-MDMA, the deuterated analogue as IS compensated for matrix effects which were slightly above the acceptable threshold (Table 3) .
Study samples
Hair specimens were obtained from 13 participants. Hair samples were analyzed in segments of 1+1+1+2 cm length from proximal to distal. Nail samples were provided by 15 subjects; 13 clippings from fingernails and 3 from toenails, and 12 scrapings from fingernails and 2 from toenails were collected, respectively. All samples were tested for MDMA and MDA enantiomers. The sum of MDA and MDMA enantiomers, respectively, was calculated. Concentrations for 5-cm hair segments were calculated as an average of the four hair segments considering segment lengths. Concentrations of MDMA and MDA enantiomers and their sum in all samples are given in Fig. 1 and Table 1 , respectively.
MDMA and MDA in hair samples
All hair segments were tested positive for MDMA and MDA enantiomers. R-and S-MDMA concentrations ranged from 101 to approximately 3200 pg/mg (median 470 pg/mg) and 71 to approximately 860 pg/mg (median 221 pg/mg), respectively (Fig. 1a, b) . The highest R-MDMA concentration (identified as outlier by Grubbs' test, α<0.01) was observed in the hair sample of participant no. 1 who was phenotyped a CYP2D6 poor metabolizer. (Fig. 1b) .
In all cases, the highest concentration of each MDMA and MDA enantiomer was found in hair segments corresponding to the time of MDMA intake based on an average hair growth rate of 1 cm per month. Accordingly, concentrations of the sum of MDMA enantiomers in hair segments corresponding to the time of intake ranged from 173 to 3770 pg/mg (median 694 pg/mg) (Fig. 2) . In all samples, MDMA and MDA could also be detected in hair segments adjacent to the one corresponding to time of intake, however, at much lower levels. Calculated concentrations IS internal standard, LOD limit of detection, LLOQ limit of quantification, QC quality control, conc. concentration, ME matrix effects, SD standard deviation of the sum of MDMA and MDA enantiomers, in 5-cm segments, varied from 78 to 850 pg/mg (median 370 pg/mg) and 3.9 to 46 pg/mg (median 19 pg/mg), respectively (Table 1) .
MDMA and MDA in nail samples
All nail clippings were tested positive for MDMA and MDA enantiomers regardless of time past MDMA intake ( Table 1 , Fig. 1c-f) . R-and S-MDMA concentrations in nail clippings ranged from 62 to approximately 990 pg/mg (median 116 pg/ mg) and from 20 to approximately 600 pg/mg (median 56 pg/ mg), respectively. R-and S-MDA concentrations in nail clippings ranged from 2.0 to 28 pg/mg (median 5.8 pg/mg) and from 2.9 to 48 pg/mg (median 6.2), respectively. By far, the highest R-/S-MDMA concentrations were detected in the toenail clipping from participant no. 12 ( Fig. 1c) . All nail scrapings were tested positive for R-and S-MDMA (Fig. 1e) with concentrations ranging from 4.3 to 303 pg/mg (median 93 pg/mg) and from 2.0 to 180 pg/mg (median 44 pg/ mg). R-and S-MDA could only be detected in 7 of 13 scrapings at low concentrations ranging from 2.3 to 12.9 pg/mg for both enantiomers (Fig. 1f) .
There was no statistical difference in the calculated sum of concentrations of MDMA and MDA enantiomers in scrapings Fig. 1 Measured R/S-MDMA and R/S-MDA concentrations in hair segments corresponding to the calculated time of intake (a, b), in nail clippings (c, d) and nail scrapings (e, f); black circle specimen from fingernail, grey circle specimen from toenail. Statistical analysis by paired, two-tailed, nonparametric t test; ****p<0.0001: extremely significant; ***p<0.001: very significant, p>0.05: not significant (ns) Fig. 2 Calculated sum of concentrations of MDMA enantiomers in four hair segments (1+1+1+2 cm, from proximal to distal) from participants with recent (a), earlier (participant no. 6 and 10), and recent with earlier (participant no. 14) intake (b). Green arrows indicate hair segments corresponding to the time of MDMA intake. Red dotted line SoHT cutoff for MDMA in hair samples. Participant no. 1 was phenotyped a CYP2D6 poor metabolizer and clippings; medians were 134 and 167 pg/mg for MDMA, and 6.3 and 12 pg/mg for MDA, respectively (Table 1) . However, the sums of MDMA and MDA enantiomers were significantly lower in nail samples compared to hair samples considering a segment length of 5 cm (Table 1) .
Enantiomer ratios of MDMA and MDA in hair and nail samples R/S-MDMA concentration ratios were higher than 1 in all hair samples (Fig. 3a) . There was no significant difference between hair segments corresponding (median 2.1) and not corresponding (median 1.9) to the time of intake (Fig. 3a) . R/S-MDMA concentration ratios were higher than 1 in all nail clippings and scrapings (medians 2.2 and 2.4, respectively) (Fig. 3a) . The highest R/S-MDMA ratio of 5.7 and 22 was observed in a hair segment and nail scraping of participant no. 1 who was a CYP2D6 poor metabolizer (Fig. 3a) .
S-MDA was detected at slightly higher amounts in hair segments in most subjects; median R/S-MDA ratios were 0.84 and 0.90, respectively (Fig. 3b) . In nail clippings and scrapings, the median enantiomer ratios for R/S-MDA were 0.77 and 0.95, respectively (Fig. 3b) . There was no significant difference for enantiomer ratios of MDMA and MDA in nail and hair samples (Fig. 3) .
Two trends of R/S-MDMA concentration ratios along the four hair segments of each participant were observed: decreasing (no. 1, 2, 4, 7, 11, 12, 13, 16, 17, and 18) and increasing (no. 6 and 10) from proximal to distal, respectively (Fig. 4) . There was no obvious trend in samples from participant no. 14 and 18 (Fig. 4) .
Metabolite ratios of MDA to MDMA in hair and nail samples MDA to MDMA ratios in corresponding and not corresponding hair segments ranged from 0.031 to 0.074 (median 0.047) and from 0.029 to 0.11 (median 0.054), respectively (Fig. 5) .
In nail clippings and scrapings, metabolite ratios ranged from 0.041 to 0.13 (median 0.055) and from 0.041 and 0.084 (median 0.044), respectively (Fig. 5) . Overall, there was no statistical difference in metabolite concentration ratios of the sum of concentrations of MDA to MDMA enantiomers in hair and nail samples.
Discussion
The analytical method applying chiral derivatization and LC-MS/MS analysis proved to be a valuable tool for the quantification of MDMA and MDA enantiomers in hair samples, nail scrapings, and nail clippings. The method is specific and highly sensitive as low LLOQ were achieved with a sample weight of as low as 20 mg hair and 5 mg nail, respectively. In forensic investigations, it is often crucial to identify the time period in which a drug was taken. Therefore, controlled drug administration studies are needed for better understanding of incorporation profiles into hair and nails.
MDMA and MDA in hair samples
As recently demonstrated, the time point of amphetamine intake could be estimated by the analysis of 0.5-cm hair segments after controlled administration of 50 mg amphetamine. However, only five out of nine study participants were tested positive [5] . In our study, all hair samples were positive for MDMA and MDA enantiomers after two representative intakes of 125 mg MDMA (Table 1, Fig. 1 ). Segmental hair analysis demonstrated that the highest concentration of MDMA enantiomers (data not shown) and the highest calculated sum of concentrations of MDMA enantiomers (Fig. 2) in hair segments correlated well with time of MDMA intake based on an average hair growth rate of 1 cm per month. However, the inter-individual variability in MDMA hair concentrations was large. In 7 of the 13 participants (no. 4, 6, 11, 12, [16] [17] [18] , one 1-cm segment covered the time of both MDMA doses. Five participants (no. 2, 7, 10, 13, 14) received the two MDMA doses with a time interval long enough to allow for monitoring by two hair segments (Fig. 2) . Intra-individual MDMA concentrations in the two hair segments of these participants were very similar (Fig. 2, Table 1 ).
The hair sample of participant no. 1 was too short to cover the time of the first MDMA intake ( Table 1 ). The highest MDMA concentration (determined as outlier by Grubbs test, p>0.05) was observed for subject no. 1 who was a CYP2D6 poor metabolizer involving a reduced elimination rate of MDMA compared to extensive metabolizers. The lowest sum of MDMA enantiomer concentrations was detected in a light brown hair sample (no. 11) (Table 1) . However, there was no significant difference between (light) brown and dark brown hair samples in MDMA concentrations in 1-, 2-, and 5-cm hair segments (data not shown). Also, Mieczkowski and Newel who reviewed different data sets stated that there is no relationship of hair color and MDMA concentrations in hair [47] .
For CYP2D6 extensive metabolizers, the median sum of MDMA enantiomer concentrations in the corresponding 1-cm and the 5-cm hair segments was 670 and 340 pg/mg, respectively (Table 1) . Applying the SoHT cut-off of 200 pg/mg for amphetamines [3] , 12 of 13 hair samples with a 1-cm segment and 10 of 13 hair samples with a 5-cm segment would have tested positive after two representative MDMA intakes (each 125 mg) within a time period of about a maximum of 3 months (94 days, median 42 days) ( Table 1) . Hair samples of participants (no. 2, 7, 10, 13, 14) in which the two intakes were represented by two different hair segments would theoretically have tested positive for MDMA only after one single intake (Fig. 2 ). Our findings demonstrate that the length of a hair segment should be considered for the interpretation of hair analysis results and application of cut-offs.
MDMA and MDA in nail samples and comparison to hair
In two previous studies, it was demonstrated that a single drug dose is detectable in fingernail clippings [24, 25] . The present study describes nail findings following two MDMA administrations. All nail samples were positive for MDMA enantiomers following a first and second administration ranging from 26 to 128 and 9 to 77 days, respectively, prior to sample collection. MDMA concentrations were below 500 pg/mg in all nail samples (Table 1) . There was no relationship between drug concentrations in nail samples and days passed after the first or second MDMA intake. Nail incorporation takes place via nail matrix and nail bed [24, 25] . In nail clippings, drugs can be detected earlier after incorporation via nail bed than via nail matrix. Drugs can be detected in nail scrapings as soon as outgrowth of incorporated drug at the nail matrix starts reaching the exposed nail surface. Moreover, sweat/sebum contribute to drug incorporation into the nail leading to drug detection already within hours after the intake.
In most subjects, MDMA and MDA concentrations of enantiomers and their sum were higher in nail clippings than in scrapings (Table 1) . In a recent study with cocaine users, cocaine concentrations were higher in scrapings compared to clippings which was explained by external contamination from drug residues in the environment [12] . In the present study, contamination can be excluded as intake was performed in the scope of a controlled study. Lower levels in scrapings may be explained by drug extraction during daily hygiene as the nail surface which is collected for scrapings is more exposed to drug extraction [12] .
Our study included the analysis of 13 fingernail and 3 toenail samples. In two toenail samples (no. 10, 16), concentrations of MDMA and MDA enantiomers and their sum were in the same range as in fingernail samples (Table 1) . Highest MDMA and MDA concentrations were detected in the toenail clipping of participant no. 12. Interestingly, the MDMA concentration in the respective toenail scraping was not significantly higher compared to other samples, and also MDA was not detectable (Fig. 1c-f , Table 1 ). Because toenails grow Fig. 4 Enantiomeric R/S-MDMA concentration ratios in four hair segments (1+1+1+2 cm, from proximal to distal) from participants with recent (a), earlier (b; no. 6 and 10), and recent with earlier intake (b; no. 14) intake. Green arrows indicate hair segments corresponding to the time of MDMA intake. Participant no. 1 was phenotyped a CYP2D6 poor metabolizer Fig. 5 Metabolic ratios of sum of concentrations of MDA and MDMA enantiomers in hair segments corresponding (corres.) and not corresponding (not corres.) to the time of intake, nail clippings, and scrapings; black square fingernail, grey square toenail. Statistical analysis by non-paired, two-tailed, nonparametric t test; p>0.05: not significant (ns) slower than fingernails [9] [10] [11] , they represent a longer window of detection for drugs. Based on an average growth rate of the great toe of 2.1 mm/month and a great toenail length of 20 mm, the nail should represent drug exposure during approximately the past 10 months [17] . Therefore, higher drug concentrations in toenail samples could be explained by drug use prior to the study. The 5-cm-long hair sample of participant no. 12 was too short to verify this assumption.
In 8 of 13 subjects, the sum of concentrations of MDMA enantiomers were lower in nail clippings compared to the 5-cm hair segment; in two participants, comparable concentrations were found (Table 1) . Cirimele et al. reported for one case slightly higher MDMA and MDA concentrations in fingernail scrapings compared to hair [20] . It should be noted that hair and nail samples represent different time frames: about 5 months based on an average growth rate if the hair sample is 5 cm long, for nail clippings a median window of detection of 3.5 months was determined [25] . However, it should be noted that the window of detection in nails depends on nail length. To our knowledge, there is no report on windows of detection in scrapings. Furthermore, the bizonal drug incorporation mechanism into nails makes time-resolved analysis impossible unless clippings are collected continuously over a longer period [25] . Despite these limitations, our findings illustrate that nail clippings can be suitably used for retrospective monitoring of drug history alternatively to hair, especially in cases where hair is not long enough or cosmetically treated, as a positive result for MDMA and MDA proves MDMA intake. Nail scrapings seem less suitable as not all samples were positive for the metabolite MDA after two single MDMA intakes.
Enantiomer ratios of MDMA and MDA in hair and nail samples R-MDMA concentrations were significantly higher than S-MDMA concentrations in all hair and nail samples, whereas no difference was observed for concentrations of MDA enantiomers (Figs. 1 and 3) . Participant no. 1, who was a CYP2D6 poor metabolizer, had the highest R/S-MDMA ratio in the hair segment corresponding to the time of intake and the nail scraping, whereas the ratio in the nail clipping was in the range of the extensive CYP2D6 metabolizers (Fig. 3a) . However, from this data, it cannot be deduced that a CYP2D6 poor metabolizer phenotype leads necessarily to a higher R/S ratio.
To our knowledge, there are two reports on chiral analysis of MDMA and MDA in hair samples from suspected or selfdeclared MDMA users [48] [49] [50] . Enantiomeric ratios for MDMA and MDA from our controlled intake study are in concordance with hair findings reported by Martins et al. from a study with self-declared MDMA users after controlled MDMA administration [48] .
Previous studies had demonstrated that plasma and urine concentrations of R-MDMA exceeded those of S-MDMA at all time points analyzed over 24 h after administration, whereas S-MDA plasma concentrations slightly exceeded those of R-MDA [36, 41] . Our study results display the same trend for hair and nail samples. This suggests that drug incorporation into hair and nails is not enantioselective and that findings in keratinzed matrices primarily reflect enantiomer proportions in blood. R/S-MDMA ratios in corresponding hair segments of all extensive CYP 2D6 metabolizers ranged from 1.4 to 2.5. Interestingly, this range overlaps with R/S-MDMA ratios observed in plasma at time points 2 to 8 h after MDMA administration with highest MDMA concentrations in the AUC curve [36, 41] . This finding may indicate that the highest proportion of drug incorporated into hair may be dependent on the maximum concentration of enantiomer or drug. Furthermore, similar enantiomeric ratios of MDMA and MDA in hair, nail clippings, and scrapings may suggest that drug incorporation into these three matrices are comparable. According to our study, we still cannot exclude passive diffusion as drug incorporation mechanism into hair as postulated by previous authors [19, 20] .
Within-subject comparison revealed two patterns for R/S-MDMA concentration ratios along the hair segments: a decreasing or increasing trend from proximal to distal segments. The decreasing and increasing trend corresponded to decreasing and increasing sum of concentrations of MDMA enantiomers along the hair segments, respectively, except for participant no. 18 ( Figs. 2 and 4) . The highest R/S-MDMA ratio in the proximal (participant no. 1, 12, 16, 4, 17, 2, 11,13, 7) or distal (participant no. 6 and 10) segments corresponded to recent or earlier MDMA administration, respectively (Fig. 4) . In the case of recent MDMA intake, lower R/S-MDMA ratios in distal segments may be explained by sweat incorporation. There was no trend for MDA enantiomeric ratios along the hair segments (data not shown).
Participant no. 14 received the two MDMA doses with a time interval of 2 months, which was monitored by significantly increased MDMA concentrations in both corresponding hair segments (Fig. 2) . The longer time interval of intakes resulted in comparable R/S-MDMA ratios along the hair segments (Fig. 4b) .
Metabolite ratios of MDA to MDMA in hair and nail samples
The determination of metabolite to parent drug ratios was recommended for the discrimination between drug intake and external contamination of a hair sample [51] and has proved to be useful [52] [53] [54] . For this purpose, metabolite ratios have to be determined after controlled intake of drug in a scope where contamination can be excluded. As routine analysis is typically achiral, the sum of the respective enantiomer concentrations were used for the metabolite ratios. In our study, median ratios of MDA to MDMA concentrations in hair following administration of pharmaceutical racemic MDMA were 0.047 in corresponding and 0.054 in not corresponding hair segments (Fig. 5) . Other authors reported similar metabolic ratios after street MDMA use (0.04 to 0.06) [55, 56] or controlled administration (<0.09) [48] .
Conclusion
A suitable analytical method for the chiral analysis of MDMA and MDA in hair and nail samples was presented. The study demonstrates that administrations of two representative single doses of MDMA can be detected in the hair segments corresponding to the time of intake and in all nail samples. As all nail clippings were positive for MDMA and the metabolite MDA irrespective of days passed after intake, clippings appears a suitable alternative to hair for prove of MDMA intake. Since no significant difference was observed for enantiomeric ratios in hair and nail samples, incorporation mechanisms into both keratinized matrices may be comparable.
